Clinical and Translational Science Center

临床和转化科学中心

基本信息

项目摘要

Contact PD/PI: IMPERATO-MCGINLEY, JULIANNE L OVERALL PROJECT SUMMARY/SUMMARY The Weill Cornell Medicine Clinical and Translational Science Center’s (CTSC) future strategies are built on the considerable accomplishments achieved over the last 14 years, providing the translation of research and the generation of research ideas that pave the way for future innovations despite the effect of the pandemic on the medical school, with the city in lockdown for over 14 months. The plans for the next five years are devised to continue to develop the existing infrastructure and its initiatives, to add new ones, to enhance networking, and to improve diversity, equity, and inclusion. In so doing, we will continue to advance translational science to improve community health. With our multi-institutional hub of distinguished partners firmly in place, the strategic plans for the CTSC are geared to rapidly advance translational science discovery by: 1) Enhancing informatics to increase resource adoption, reduce roadblocks and streamline workflow through training, novel software, and new collaborations; 2) Improving health inequities, developing strong translational research engagement with communites, and preparing for health crises, like the COVID-19 pandemic, where the CTSC organized a vaccination hesitancy program and set up vaccination sites in underserved communities; 3) Continuing to develop our highly successful clinical and translational education programs through innovative and entrepreneurial multifaceted initiatives including training in health disparities and a new cross-hub KL2/TL1 collaboration with the Georgetown/Howard CTSA; and 4) Creating Team Science initiatives that promote inclusion across the CTSC. Innovative didactic opportunities will continue to be offered and expanded, such as seminars on innovation and entrepreneurship, the newest of which will be a collaborate with eLab on “Unmet Needs for Stimulating Device Development,” a five-part series which is designed to stimulate device development. The Pilot Translational and Clinical Studies program will be enhanced to target projects in device and therapeutics development, precision medicine and research in special populations while promoting collaborations between the community, community organizations and CTSC Investigators. The CTSC also offers educative opportunities that reach the broader community such as our Teaching Ethics Through Art program, while the Special Population Network (SPN) will expand to include community outreach studies and continue clinical research studies with a focus on the following populations: children, the elderly, ethnic and racial minorities and those with disabilities. Additionally, the Network Capacity Component will do more outreach to encourage local investigators to initiate multi-center clinical trials. The CTSC has also been extremely successful ensuring the availability of biostatisticians from all partners with expertise in diverse disease systems and with adequate computational resources to support the design and conduct of research studies performed within the CTSC. All of these initiatives allow the CTSC to accomplish its goal of translating science to improve public health more effectively and efficiently. Project Summary/Abstract Page 298 Contact PD/PI: IMPERATO-MCGINLEY, JULIANNE L
联系PD/PI:IMPERATO-MCGINLEY,Julianne L 整体 项目概要/概要 威尔康奈尔医学临床和转化科学中心(CTSC)的未来战略是建立在 在过去的14年里取得了相当大的成就,提供了翻译的研究和 尽管大流行病影响了世界卫生组织,但仍产生了为未来创新铺平道路的研究思路。 医学院,城市被封锁了14个月。未来五年的计划旨在 继续发展现有的基础设施及其举措,增加新的基础设施,加强网络联系, 改善多样性、公平性和包容性。在此过程中,我们将继续推进转化科学, 改善社区卫生。凭借我们由杰出合作伙伴组成的多机构中心, CTSC计划通过以下方式快速推进转化科学发现:1)加强信息学 通过培训、新型软件和 新的合作; 2)改善卫生不公平,发展强大的转化研究参与, 社区,并为健康危机做好准备,如COVID-19大流行,CTSC组织了一次 疫苗接种犹豫计划,并在服务不足的社区设立疫苗接种点; 3)继续 发展我们非常成功的临床和转化教育计划,通过创新和 多方面的创业举措,包括健康差距方面的培训和新的交叉枢纽KL 2/TL 1 与乔治敦/霍华德CTSA合作;以及4)创建团队科学计划, 在CTSC中的应用。创新的教学机会将继续提供和扩大,如 关于创新和创业的研讨会,其中最新的将是与eLab合作举办的“未满足”研讨会 刺激设备开发的需求”,一个由五部分组成的系列,旨在刺激设备 发展将加强试点转化和临床研究计划,以针对器械中的项目 和治疗方法的发展,精准医学和特殊人群的研究,同时促进 社区、社区组织和CTSC调查人员之间的合作。CTSC还提供 教育机会,达到更广泛的社区,如我们的教学道德通过艺术计划, 而特殊人口网络(SPN)将扩大到包括社区外展研究, 临床研究,重点关注以下人群:儿童、老年人、人种和种族 少数民族和残疾人。此外,网络能力构成部分将开展更多外联活动, 鼓励当地研究者开展多中心临床试验。CTSC也非常成功 确保来自所有合作伙伴的生物统计学家具有不同疾病系统的专门知识, 足够的计算资源,以支持设计和进行的研究, CTSC。所有这些举措使CTSC能够实现其将科学转化为改善公众健康的目标。 更有效、更高效地开展卫生工作。 项目摘要/摘要第298页 联系PD/PI:IMPERATO-MCGINLEY,Julianne L

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JULIANNE L IMPERATO-MCGINLEY其他文献

JULIANNE L IMPERATO-MCGINLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JULIANNE L IMPERATO-MCGINLEY', 18)}}的其他基金

Clinical and Translational Science Center
临床和转化科学中心
  • 批准号:
    10673813
  • 财政年份:
    2017
  • 资助金额:
    $ 1004.8万
  • 项目类别:
Disparities in COVID Disease Severity and Outcomes in New York City
纽约市新冠疾病严重程度和结果的差异
  • 批准号:
    10159057
  • 财政年份:
    2017
  • 资助金额:
    $ 1004.8万
  • 项目类别:
Clinical and Translational Science Center
临床和转化科学中心
  • 批准号:
    9977298
  • 财政年份:
    2017
  • 资助金额:
    $ 1004.8万
  • 项目类别:
Clinical and Translational Science Center
临床和转化科学中心
  • 批准号:
    10213868
  • 财政年份:
    2017
  • 资助金额:
    $ 1004.8万
  • 项目类别:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
  • 批准号:
    8366103
  • 财政年份:
    2011
  • 资助金额:
    $ 1004.8万
  • 项目类别:
CLINICAL AND TRANSLATIONAL SCIENCE CENTER
临床和转化科学中心
  • 批准号:
    8366104
  • 财政年份:
    2011
  • 资助金额:
    $ 1004.8万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8366105
  • 财政年份:
    2011
  • 资助金额:
    $ 1004.8万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8366102
  • 财政年份:
    2011
  • 资助金额:
    $ 1004.8万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8366101
  • 财政年份:
    2011
  • 资助金额:
    $ 1004.8万
  • 项目类别:
Clinical and Translational Science Center (UL1)
临床和转化科学中心 (UL1)
  • 批准号:
    8140982
  • 财政年份:
    2010
  • 资助金额:
    $ 1004.8万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1004.8万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了